EFFIX
LIVE

Serial Number

79443342

Owner

WuXi Biologics (Hangzhou) Co., Ltd.

Filing Date

Jun 26, 2025

Add to watchlist:

No watchlists yet
View on USPTO

EFFIX Trademark

Serial Number: 79443342

EFFIX is a trademark filed by WuXi Biologics (Hangzhou) Co., Ltd. on June 26, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

WuXi Biologics (Hangzhou) Co., Ltd.

1st-4th Floor, Building 3, Heke Technology Center,

Entity Type: 16

Trademark Details

Filing Date

June 26, 2025

Registration Date

Not Registered

Goods & Services

Biological preparations for medical purposes; preparations of microorganisms for medical or veterinary use; pharmaceutical preparations; medicines for human purposes; biological preparations for veterinary purposes; veterinary preparations; medicines for veterinary purposes; cells for medical use; bacterial preparations for medical use; live cells for veterinary use; bacterial preparations for veterinary use.

Biological preparations, other than for medical or veterinary purposes; preparations of microorganisms, other than for medical and veterinary use; bacterial preparations, other than for medical and veterinary use; bacteriological preparations, other than for medical and veterinary use; biochemical reagents for scientific use; biochemical reagents, other than for medical use; collagen for industrial purposes; proteins for use in manufacture; protein [raw material]; proteins for industrial purposes; chemical additives for use in the manufacture of cosmetics; proteins for the food industry; proteins for use in the manufacture of cosmetics.

Custom assembling of materials for others; processing and treatment of chemical reagents; custom manufacturing of cosmetics; custom manufacturing of pharmaceuticals; customized production service of biological preparations; custom manufacturing of biomedical preparations; custom manufacturing of biotechnology drugs; custom manufacturing of antibody drugs; custom manufacturing of pharmaceuticals; custom manufacturing of biopharmaceuticals.

Consulting services in the field of technology development; research and development of new products for others; scientific research and development; biochemical research and analysis; pharmaceutical development services; pharmaceutical research services; research in the field of synthetic biology; development of pharmaceutical preparations and medicines; biomedical research services; research and development services in the field of gene expression systems.

Filing History

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 17, 2026 RFCR
NON-FINAL ACTION WRITTEN
Feb 16, 2026 CNRT
ASSIGNED TO EXAMINER
Feb 16, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 15, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 15, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 12, 2026 REPR